Global Human Factor VIII Concentrate Market Research Report 2023
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Factor VIII Concentrate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
By Company
- Pfizer
- Novo Nordisk A/S
- Shire (Baxter)
- Bayer
- GC Pharma
- Shanghai Raas Corp
- Hualan Biological
- Shandong Taibang Biological Products
- Shanghai Xinxing Medicine
- SinoCell Tech
- CSL
- Grifols
- Biogen
- Octapharma
- NovoNordisk
- Blood Extraction
- Recombine
- Congenital Coagulation Factor VIII Deficiency
- Acquired Factor VIII Deficiency
- Von Willebrand's Disease
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 HUMAN FACTOR VIII CONCENTRATE MARKET OVERVIEW
1.1 Product Overview and Scope of Human Factor VIII Concentrate
1.2 Human Factor VIII Concentrate Segment by Type
1.2.1 Global Human Factor VIII Concentrate Market Value Comparison by Type (2023-2029)
1.2.2 Blood Extraction
1.2.3 Recombine
1.3 Human Factor VIII Concentrate Segment by Application
1.3.1 Global Human Factor VIII Concentrate Market Value by Application: (2023-2029)
1.3.2 Congenital Coagulation Factor VIII Deficiency
1.3.3 Acquired Factor VIII Deficiency
1.3.4 Von Willebrand's Disease
1.4 Global Human Factor VIII Concentrate Market Size Estimates and Forecasts
1.4.1 Global Human Factor VIII Concentrate Revenue 2018-2029
1.4.2 Global Human Factor VIII Concentrate Sales 2018-2029
1.4.3 Global Human Factor VIII Concentrate Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 HUMAN FACTOR VIII CONCENTRATE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Human Factor VIII Concentrate Sales Market Share by Manufacturers (2018-2023)
2.2 Global Human Factor VIII Concentrate Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Human Factor VIII Concentrate Average Price by Manufacturers (2018-2023)
2.4 Global Human Factor VIII Concentrate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Human Factor VIII Concentrate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Factor VIII Concentrate, Product Type & Application
2.7 Human Factor VIII Concentrate Market Competitive Situation and Trends
2.7.1 Human Factor VIII Concentrate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Factor VIII Concentrate Players Market Share by Revenue
2.7.3 Global Human Factor VIII Concentrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HUMAN FACTOR VIII CONCENTRATE RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Human Factor VIII Concentrate Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Factor VIII Concentrate Global Human Factor VIII Concentrate Sales by Region: 2018-2029
3.2.1 Global Human Factor VIII Concentrate Sales by Region: 2018-2023
3.2.2 Global Human Factor VIII Concentrate Sales by Region: 2024-2029
3.3 Global Human Factor VIII Concentrate Global Human Factor VIII Concentrate Revenue by Region: 2018-2029
3.3.1 Global Human Factor VIII Concentrate Revenue by Region: 2018-2023
3.3.2 Global Human Factor VIII Concentrate Revenue by Region: 2024-2029
3.4 North America Human Factor VIII Concentrate Market Facts & Figures by Country
3.4.1 North America Human Factor VIII Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Factor VIII Concentrate Sales by Country (2018-2029)
3.4.3 North America Human Factor VIII Concentrate Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Factor VIII Concentrate Market Facts & Figures by Country
3.5.1 Europe Human Factor VIII Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Factor VIII Concentrate Sales by Country (2018-2029)
3.5.3 Europe Human Factor VIII Concentrate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Factor VIII Concentrate Market Facts & Figures by Country
3.6.1 Asia Pacific Human Factor VIII Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Factor VIII Concentrate Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Factor VIII Concentrate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Factor VIII Concentrate Market Facts & Figures by Country
3.7.1 Latin America Human Factor VIII Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Factor VIII Concentrate Sales by Country (2018-2029)
3.7.3 Latin America Human Factor VIII Concentrate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Factor VIII Concentrate Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Factor VIII Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Factor VIII Concentrate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Factor VIII Concentrate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Human Factor VIII Concentrate Sales by Type (2018-2029)
4.1.1 Global Human Factor VIII Concentrate Sales by Type (2018-2023)
4.1.2 Global Human Factor VIII Concentrate Sales by Type (2024-2029)
4.1.3 Global Human Factor VIII Concentrate Sales Market Share by Type (2018-2029)
4.2 Global Human Factor VIII Concentrate Revenue by Type (2018-2029)
4.2.1 Global Human Factor VIII Concentrate Revenue by Type (2018-2023)
4.2.2 Global Human Factor VIII Concentrate Revenue by Type (2024-2029)
4.2.3 Global Human Factor VIII Concentrate Revenue Market Share by Type (2018-2029)
4.3 Global Human Factor VIII Concentrate Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Human Factor VIII Concentrate Sales by Application (2018-2029)
5.1.1 Global Human Factor VIII Concentrate Sales by Application (2018-2023)
5.1.2 Global Human Factor VIII Concentrate Sales by Application (2024-2029)
5.1.3 Global Human Factor VIII Concentrate Sales Market Share by Application (2018-2029)
5.2 Global Human Factor VIII Concentrate Revenue by Application (2018-2029)
5.2.1 Global Human Factor VIII Concentrate Revenue by Application (2018-2023)
5.2.2 Global Human Factor VIII Concentrate Revenue by Application (2024-2029)
5.2.3 Global Human Factor VIII Concentrate Revenue Market Share by Application (2018-2029)
5.3 Global Human Factor VIII Concentrate Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Human Factor VIII Concentrate Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novo Nordisk A/S
6.2.1 Novo Nordisk A/S Corporation Information
6.2.2 Novo Nordisk A/S Description and Business Overview
6.2.3 Novo Nordisk A/S Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novo Nordisk A/S Human Factor VIII Concentrate Product Portfolio
6.2.5 Novo Nordisk A/S Recent Developments/Updates
6.3 Shire (Baxter)
6.3.1 Shire (Baxter) Corporation Information
6.3.2 Shire (Baxter) Description and Business Overview
6.3.3 Shire (Baxter) Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Shire (Baxter) Human Factor VIII Concentrate Product Portfolio
6.3.5 Shire (Baxter) Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer Human Factor VIII Concentrate Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 GC Pharma
6.5.1 GC Pharma Corporation Information
6.5.2 GC Pharma Description and Business Overview
6.5.3 GC Pharma Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GC Pharma Human Factor VIII Concentrate Product Portfolio
6.5.5 GC Pharma Recent Developments/Updates
6.6 Shanghai Raas Corp
6.6.1 Shanghai Raas Corp Corporation Information
6.6.2 Shanghai Raas Corp Description and Business Overview
6.6.3 Shanghai Raas Corp Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Shanghai Raas Corp Human Factor VIII Concentrate Product Portfolio
6.6.5 Shanghai Raas Corp Recent Developments/Updates
6.7 Hualan Biological
6.6.1 Hualan Biological Corporation Information
6.6.2 Hualan Biological Description and Business Overview
6.6.3 Hualan Biological Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hualan Biological Human Factor VIII Concentrate Product Portfolio
6.7.5 Hualan Biological Recent Developments/Updates
6.8 Shandong Taibang Biological Products
6.8.1 Shandong Taibang Biological Products Corporation Information
6.8.2 Shandong Taibang Biological Products Description and Business Overview
6.8.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Product Portfolio
6.8.5 Shandong Taibang Biological Products Recent Developments/Updates
6.9 Shanghai Xinxing Medicine
6.9.1 Shanghai Xinxing Medicine Corporation Information
6.9.2 Shanghai Xinxing Medicine Description and Business Overview
6.9.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product Portfolio
6.9.5 Shanghai Xinxing Medicine Recent Developments/Updates
6.10 SinoCell Tech
6.10.1 SinoCell Tech Corporation Information
6.10.2 SinoCell Tech Description and Business Overview
6.10.3 SinoCell Tech Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.10.4 SinoCell Tech Human Factor VIII Concentrate Product Portfolio
6.10.5 SinoCell Tech Recent Developments/Updates
6.11 CSL
6.11.1 CSL Corporation Information
6.11.2 CSL Human Factor VIII Concentrate Description and Business Overview
6.11.3 CSL Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.11.4 CSL Human Factor VIII Concentrate Product Portfolio
6.11.5 CSL Recent Developments/Updates
6.12 Grifols
6.12.1 Grifols Corporation Information
6.12.2 Grifols Human Factor VIII Concentrate Description and Business Overview
6.12.3 Grifols Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Grifols Human Factor VIII Concentrate Product Portfolio
6.12.5 Grifols Recent Developments/Updates
6.13 Biogen
6.13.1 Biogen Corporation Information
6.13.2 Biogen Human Factor VIII Concentrate Description and Business Overview
6.13.3 Biogen Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Biogen Human Factor VIII Concentrate Product Portfolio
6.13.5 Biogen Recent Developments/Updates
6.14 Octapharma
6.14.1 Octapharma Corporation Information
6.14.2 Octapharma Human Factor VIII Concentrate Description and Business Overview
6.14.3 Octapharma Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Octapharma Human Factor VIII Concentrate Product Portfolio
6.14.5 Octapharma Recent Developments/Updates
6.15 NovoNordisk
6.15.1 NovoNordisk Corporation Information
6.15.2 NovoNordisk Human Factor VIII Concentrate Description and Business Overview
6.15.3 NovoNordisk Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.15.4 NovoNordisk Human Factor VIII Concentrate Product Portfolio
6.15.5 NovoNordisk Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Human Factor VIII Concentrate Industry Chain Analysis
7.2 Human Factor VIII Concentrate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Factor VIII Concentrate Production Mode & Process
7.4 Human Factor VIII Concentrate Sales and Marketing
7.4.1 Human Factor VIII Concentrate Sales Channels
7.4.2 Human Factor VIII Concentrate Distributors
7.5 Human Factor VIII Concentrate Customers
8 HUMAN FACTOR VIII CONCENTRATE MARKET DYNAMICS
8.1 Human Factor VIII Concentrate Industry Trends
8.2 Human Factor VIII Concentrate Market Drivers
8.3 Human Factor VIII Concentrate Market Challenges
8.4 Human Factor VIII Concentrate Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Human Factor VIII Concentrate
1.2 Human Factor VIII Concentrate Segment by Type
1.2.1 Global Human Factor VIII Concentrate Market Value Comparison by Type (2023-2029)
1.2.2 Blood Extraction
1.2.3 Recombine
1.3 Human Factor VIII Concentrate Segment by Application
1.3.1 Global Human Factor VIII Concentrate Market Value by Application: (2023-2029)
1.3.2 Congenital Coagulation Factor VIII Deficiency
1.3.3 Acquired Factor VIII Deficiency
1.3.4 Von Willebrand's Disease
1.4 Global Human Factor VIII Concentrate Market Size Estimates and Forecasts
1.4.1 Global Human Factor VIII Concentrate Revenue 2018-2029
1.4.2 Global Human Factor VIII Concentrate Sales 2018-2029
1.4.3 Global Human Factor VIII Concentrate Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 HUMAN FACTOR VIII CONCENTRATE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Human Factor VIII Concentrate Sales Market Share by Manufacturers (2018-2023)
2.2 Global Human Factor VIII Concentrate Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Human Factor VIII Concentrate Average Price by Manufacturers (2018-2023)
2.4 Global Human Factor VIII Concentrate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Human Factor VIII Concentrate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Factor VIII Concentrate, Product Type & Application
2.7 Human Factor VIII Concentrate Market Competitive Situation and Trends
2.7.1 Human Factor VIII Concentrate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Factor VIII Concentrate Players Market Share by Revenue
2.7.3 Global Human Factor VIII Concentrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HUMAN FACTOR VIII CONCENTRATE RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Human Factor VIII Concentrate Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Factor VIII Concentrate Global Human Factor VIII Concentrate Sales by Region: 2018-2029
3.2.1 Global Human Factor VIII Concentrate Sales by Region: 2018-2023
3.2.2 Global Human Factor VIII Concentrate Sales by Region: 2024-2029
3.3 Global Human Factor VIII Concentrate Global Human Factor VIII Concentrate Revenue by Region: 2018-2029
3.3.1 Global Human Factor VIII Concentrate Revenue by Region: 2018-2023
3.3.2 Global Human Factor VIII Concentrate Revenue by Region: 2024-2029
3.4 North America Human Factor VIII Concentrate Market Facts & Figures by Country
3.4.1 North America Human Factor VIII Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Factor VIII Concentrate Sales by Country (2018-2029)
3.4.3 North America Human Factor VIII Concentrate Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Factor VIII Concentrate Market Facts & Figures by Country
3.5.1 Europe Human Factor VIII Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Factor VIII Concentrate Sales by Country (2018-2029)
3.5.3 Europe Human Factor VIII Concentrate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Factor VIII Concentrate Market Facts & Figures by Country
3.6.1 Asia Pacific Human Factor VIII Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Factor VIII Concentrate Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Factor VIII Concentrate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Factor VIII Concentrate Market Facts & Figures by Country
3.7.1 Latin America Human Factor VIII Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Factor VIII Concentrate Sales by Country (2018-2029)
3.7.3 Latin America Human Factor VIII Concentrate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Factor VIII Concentrate Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Factor VIII Concentrate Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Factor VIII Concentrate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Factor VIII Concentrate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Human Factor VIII Concentrate Sales by Type (2018-2029)
4.1.1 Global Human Factor VIII Concentrate Sales by Type (2018-2023)
4.1.2 Global Human Factor VIII Concentrate Sales by Type (2024-2029)
4.1.3 Global Human Factor VIII Concentrate Sales Market Share by Type (2018-2029)
4.2 Global Human Factor VIII Concentrate Revenue by Type (2018-2029)
4.2.1 Global Human Factor VIII Concentrate Revenue by Type (2018-2023)
4.2.2 Global Human Factor VIII Concentrate Revenue by Type (2024-2029)
4.2.3 Global Human Factor VIII Concentrate Revenue Market Share by Type (2018-2029)
4.3 Global Human Factor VIII Concentrate Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Human Factor VIII Concentrate Sales by Application (2018-2029)
5.1.1 Global Human Factor VIII Concentrate Sales by Application (2018-2023)
5.1.2 Global Human Factor VIII Concentrate Sales by Application (2024-2029)
5.1.3 Global Human Factor VIII Concentrate Sales Market Share by Application (2018-2029)
5.2 Global Human Factor VIII Concentrate Revenue by Application (2018-2029)
5.2.1 Global Human Factor VIII Concentrate Revenue by Application (2018-2023)
5.2.2 Global Human Factor VIII Concentrate Revenue by Application (2024-2029)
5.2.3 Global Human Factor VIII Concentrate Revenue Market Share by Application (2018-2029)
5.3 Global Human Factor VIII Concentrate Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Human Factor VIII Concentrate Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novo Nordisk A/S
6.2.1 Novo Nordisk A/S Corporation Information
6.2.2 Novo Nordisk A/S Description and Business Overview
6.2.3 Novo Nordisk A/S Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novo Nordisk A/S Human Factor VIII Concentrate Product Portfolio
6.2.5 Novo Nordisk A/S Recent Developments/Updates
6.3 Shire (Baxter)
6.3.1 Shire (Baxter) Corporation Information
6.3.2 Shire (Baxter) Description and Business Overview
6.3.3 Shire (Baxter) Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Shire (Baxter) Human Factor VIII Concentrate Product Portfolio
6.3.5 Shire (Baxter) Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer Human Factor VIII Concentrate Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 GC Pharma
6.5.1 GC Pharma Corporation Information
6.5.2 GC Pharma Description and Business Overview
6.5.3 GC Pharma Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GC Pharma Human Factor VIII Concentrate Product Portfolio
6.5.5 GC Pharma Recent Developments/Updates
6.6 Shanghai Raas Corp
6.6.1 Shanghai Raas Corp Corporation Information
6.6.2 Shanghai Raas Corp Description and Business Overview
6.6.3 Shanghai Raas Corp Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Shanghai Raas Corp Human Factor VIII Concentrate Product Portfolio
6.6.5 Shanghai Raas Corp Recent Developments/Updates
6.7 Hualan Biological
6.6.1 Hualan Biological Corporation Information
6.6.2 Hualan Biological Description and Business Overview
6.6.3 Hualan Biological Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hualan Biological Human Factor VIII Concentrate Product Portfolio
6.7.5 Hualan Biological Recent Developments/Updates
6.8 Shandong Taibang Biological Products
6.8.1 Shandong Taibang Biological Products Corporation Information
6.8.2 Shandong Taibang Biological Products Description and Business Overview
6.8.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Product Portfolio
6.8.5 Shandong Taibang Biological Products Recent Developments/Updates
6.9 Shanghai Xinxing Medicine
6.9.1 Shanghai Xinxing Medicine Corporation Information
6.9.2 Shanghai Xinxing Medicine Description and Business Overview
6.9.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product Portfolio
6.9.5 Shanghai Xinxing Medicine Recent Developments/Updates
6.10 SinoCell Tech
6.10.1 SinoCell Tech Corporation Information
6.10.2 SinoCell Tech Description and Business Overview
6.10.3 SinoCell Tech Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.10.4 SinoCell Tech Human Factor VIII Concentrate Product Portfolio
6.10.5 SinoCell Tech Recent Developments/Updates
6.11 CSL
6.11.1 CSL Corporation Information
6.11.2 CSL Human Factor VIII Concentrate Description and Business Overview
6.11.3 CSL Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.11.4 CSL Human Factor VIII Concentrate Product Portfolio
6.11.5 CSL Recent Developments/Updates
6.12 Grifols
6.12.1 Grifols Corporation Information
6.12.2 Grifols Human Factor VIII Concentrate Description and Business Overview
6.12.3 Grifols Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Grifols Human Factor VIII Concentrate Product Portfolio
6.12.5 Grifols Recent Developments/Updates
6.13 Biogen
6.13.1 Biogen Corporation Information
6.13.2 Biogen Human Factor VIII Concentrate Description and Business Overview
6.13.3 Biogen Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Biogen Human Factor VIII Concentrate Product Portfolio
6.13.5 Biogen Recent Developments/Updates
6.14 Octapharma
6.14.1 Octapharma Corporation Information
6.14.2 Octapharma Human Factor VIII Concentrate Description and Business Overview
6.14.3 Octapharma Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Octapharma Human Factor VIII Concentrate Product Portfolio
6.14.5 Octapharma Recent Developments/Updates
6.15 NovoNordisk
6.15.1 NovoNordisk Corporation Information
6.15.2 NovoNordisk Human Factor VIII Concentrate Description and Business Overview
6.15.3 NovoNordisk Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2018-2023)
6.15.4 NovoNordisk Human Factor VIII Concentrate Product Portfolio
6.15.5 NovoNordisk Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Human Factor VIII Concentrate Industry Chain Analysis
7.2 Human Factor VIII Concentrate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Factor VIII Concentrate Production Mode & Process
7.4 Human Factor VIII Concentrate Sales and Marketing
7.4.1 Human Factor VIII Concentrate Sales Channels
7.4.2 Human Factor VIII Concentrate Distributors
7.5 Human Factor VIII Concentrate Customers
8 HUMAN FACTOR VIII CONCENTRATE MARKET DYNAMICS
8.1 Human Factor VIII Concentrate Industry Trends
8.2 Human Factor VIII Concentrate Market Drivers
8.3 Human Factor VIII Concentrate Market Challenges
8.4 Human Factor VIII Concentrate Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Human Factor VIII Concentrate Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Human Factor VIII Concentrate Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Human Factor VIII Concentrate Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Factor VIII Concentrate Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Human Factor VIII Concentrate Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Human Factor VIII Concentrate Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Human Factor VIII Concentrate Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Human Factor VIII Concentrate Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Human Factor VIII Concentrate, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Human Factor VIII Concentrate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Factor VIII Concentrate, Product Type & Application
Table 12. Global Key Manufacturers of Human Factor VIII Concentrate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Factor VIII Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Factor VIII Concentrate as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Factor VIII Concentrate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Factor VIII Concentrate Sales by Region (2018-2023) & (K Units)
Table 18. Global Human Factor VIII Concentrate Sales Market Share by Region (2018-2023)
Table 19. Global Human Factor VIII Concentrate Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Factor VIII Concentrate Sales Market Share by Region (2024-2029)
Table 21. Global Human Factor VIII Concentrate Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Human Factor VIII Concentrate Revenue Market Share by Region (2018-2023)
Table 23. Global Human Factor VIII Concentrate Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Factor VIII Concentrate Revenue Market Share by Region (2024-2029)
Table 25. North America Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 27. North America Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 32. Europe Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Factor VIII Concentrate Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Factor VIII Concentrate Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Human Factor VIII Concentrate Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Factor VIII Concentrate Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Human Factor VIII Concentrate Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Factor VIII Concentrate Sales (K Units) by Type (2018-2023)
Table 51. Global Human Factor VIII Concentrate Sales (K Units) by Type (2024-2029)
Table 52. Global Human Factor VIII Concentrate Sales Market Share by Type (2018-2023)
Table 53. Global Human Factor VIII Concentrate Sales Market Share by Type (2024-2029)
Table 54. Global Human Factor VIII Concentrate Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Human Factor VIII Concentrate Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Factor VIII Concentrate Revenue Market Share by Type (2018-2023)
Table 57. Global Human Factor VIII Concentrate Revenue Market Share by Type (2024-2029)
Table 58. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2018-2023)
Table 59. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2024-2029)
Table 60. Global Human Factor VIII Concentrate Sales (K Units) by Application (2018-2023)
Table 61. Global Human Factor VIII Concentrate Sales (K Units) by Application (2024-2029)
Table 62. Global Human Factor VIII Concentrate Sales Market Share by Application (2018-2023)
Table 63. Global Human Factor VIII Concentrate Sales Market Share by Application (2024-2029)
Table 64. Global Human Factor VIII Concentrate Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Human Factor VIII Concentrate Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Factor VIII Concentrate Revenue Market Share by Application (2018-2023)
Table 67. Global Human Factor VIII Concentrate Revenue Market Share by Application (2024-2029)
Table 68. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2018-2023)
Table 69. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Human Factor VIII Concentrate Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novo Nordisk A/S Corporation Information
Table 76. Novo Nordisk A/S Description and Business Overview
Table 77. Novo Nordisk A/S Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Novo Nordisk A/S Human Factor VIII Concentrate Product
Table 79. Novo Nordisk A/S Recent Developments/Updates
Table 80. Shire (Baxter) Corporation Information
Table 81. Shire (Baxter) Description and Business Overview
Table 82. Shire (Baxter) Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Shire (Baxter) Human Factor VIII Concentrate Product
Table 84. Shire (Baxter) Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Bayer Human Factor VIII Concentrate Product
Table 89. Bayer Recent Developments/Updates
Table 90. GC Pharma Corporation Information
Table 91. GC Pharma Description and Business Overview
Table 92. GC Pharma Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GC Pharma Human Factor VIII Concentrate Product
Table 94. GC Pharma Recent Developments/Updates
Table 95. Shanghai Raas Corp Corporation Information
Table 96. Shanghai Raas Corp Description and Business Overview
Table 97. Shanghai Raas Corp Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Shanghai Raas Corp Human Factor VIII Concentrate Product
Table 99. Shanghai Raas Corp Recent Developments/Updates
Table 100. Hualan Biological Corporation Information
Table 101. Hualan Biological Description and Business Overview
Table 102. Hualan Biological Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Hualan Biological Human Factor VIII Concentrate Product
Table 104. Hualan Biological Recent Developments/Updates
Table 105. Shandong Taibang Biological Products Corporation Information
Table 106. Shandong Taibang Biological Products Description and Business Overview
Table 107. Shandong Taibang Biological Products Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Shandong Taibang Biological Products Human Factor VIII Concentrate Product
Table 109. Shandong Taibang Biological Products Recent Developments/Updates
Table 110. Shanghai Xinxing Medicine Corporation Information
Table 111. Shanghai Xinxing Medicine Description and Business Overview
Table 112. Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product
Table 114. Shanghai Xinxing Medicine Recent Developments/Updates
Table 115. SinoCell Tech Corporation Information
Table 116. SinoCell Tech Description and Business Overview
Table 117. SinoCell Tech Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. SinoCell Tech Human Factor VIII Concentrate Product
Table 119. SinoCell Tech Recent Developments/Updates
Table 120. CSL Corporation Information
Table 121. CSL Description and Business Overview
Table 122. CSL Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. CSL Human Factor VIII Concentrate Product
Table 124. CSL Recent Developments/Updates
Table 125. Grifols Corporation Information
Table 126. Grifols Description and Business Overview
Table 127. Grifols Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Grifols Human Factor VIII Concentrate Product
Table 129. Grifols Recent Developments/Updates
Table 130. Biogen Corporation Information
Table 131. Biogen Description and Business Overview
Table 132. Biogen Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Biogen Human Factor VIII Concentrate Product
Table 134. Biogen Recent Developments/Updates
Table 135. Octapharma Corporation Information
Table 136. Octapharma Description and Business Overview
Table 137. Octapharma Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Octapharma Human Factor VIII Concentrate Product
Table 139. Octapharma Recent Developments/Updates
Table 140. NovoNordisk Corporation Information
Table 141. NovoNordisk Description and Business Overview
Table 142. NovoNordisk Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. NovoNordisk Human Factor VIII Concentrate Product
Table 144. NovoNordisk Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Human Factor VIII Concentrate Distributors List
Table 148. Human Factor VIII Concentrate Customers List
Table 149. Human Factor VIII Concentrate Market Trends
Table 150. Human Factor VIII Concentrate Market Drivers
Table 151. Human Factor VIII Concentrate Market Challenges
Table 152. Human Factor VIII Concentrate Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 1. Global Human Factor VIII Concentrate Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Human Factor VIII Concentrate Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Human Factor VIII Concentrate Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Factor VIII Concentrate Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Human Factor VIII Concentrate Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Human Factor VIII Concentrate Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Human Factor VIII Concentrate Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Human Factor VIII Concentrate Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Human Factor VIII Concentrate, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Human Factor VIII Concentrate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Factor VIII Concentrate, Product Type & Application
Table 12. Global Key Manufacturers of Human Factor VIII Concentrate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Factor VIII Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Factor VIII Concentrate as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Factor VIII Concentrate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Factor VIII Concentrate Sales by Region (2018-2023) & (K Units)
Table 18. Global Human Factor VIII Concentrate Sales Market Share by Region (2018-2023)
Table 19. Global Human Factor VIII Concentrate Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Factor VIII Concentrate Sales Market Share by Region (2024-2029)
Table 21. Global Human Factor VIII Concentrate Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Human Factor VIII Concentrate Revenue Market Share by Region (2018-2023)
Table 23. Global Human Factor VIII Concentrate Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Factor VIII Concentrate Revenue Market Share by Region (2024-2029)
Table 25. North America Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 27. North America Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 32. Europe Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Factor VIII Concentrate Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Factor VIII Concentrate Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Human Factor VIII Concentrate Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Factor VIII Concentrate Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Human Factor VIII Concentrate Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Factor VIII Concentrate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Factor VIII Concentrate Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Human Factor VIII Concentrate Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Factor VIII Concentrate Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Human Factor VIII Concentrate Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Factor VIII Concentrate Sales (K Units) by Type (2018-2023)
Table 51. Global Human Factor VIII Concentrate Sales (K Units) by Type (2024-2029)
Table 52. Global Human Factor VIII Concentrate Sales Market Share by Type (2018-2023)
Table 53. Global Human Factor VIII Concentrate Sales Market Share by Type (2024-2029)
Table 54. Global Human Factor VIII Concentrate Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Human Factor VIII Concentrate Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Factor VIII Concentrate Revenue Market Share by Type (2018-2023)
Table 57. Global Human Factor VIII Concentrate Revenue Market Share by Type (2024-2029)
Table 58. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2018-2023)
Table 59. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2024-2029)
Table 60. Global Human Factor VIII Concentrate Sales (K Units) by Application (2018-2023)
Table 61. Global Human Factor VIII Concentrate Sales (K Units) by Application (2024-2029)
Table 62. Global Human Factor VIII Concentrate Sales Market Share by Application (2018-2023)
Table 63. Global Human Factor VIII Concentrate Sales Market Share by Application (2024-2029)
Table 64. Global Human Factor VIII Concentrate Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Human Factor VIII Concentrate Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Factor VIII Concentrate Revenue Market Share by Application (2018-2023)
Table 67. Global Human Factor VIII Concentrate Revenue Market Share by Application (2024-2029)
Table 68. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2018-2023)
Table 69. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Human Factor VIII Concentrate Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novo Nordisk A/S Corporation Information
Table 76. Novo Nordisk A/S Description and Business Overview
Table 77. Novo Nordisk A/S Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Novo Nordisk A/S Human Factor VIII Concentrate Product
Table 79. Novo Nordisk A/S Recent Developments/Updates
Table 80. Shire (Baxter) Corporation Information
Table 81. Shire (Baxter) Description and Business Overview
Table 82. Shire (Baxter) Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Shire (Baxter) Human Factor VIII Concentrate Product
Table 84. Shire (Baxter) Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Bayer Human Factor VIII Concentrate Product
Table 89. Bayer Recent Developments/Updates
Table 90. GC Pharma Corporation Information
Table 91. GC Pharma Description and Business Overview
Table 92. GC Pharma Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GC Pharma Human Factor VIII Concentrate Product
Table 94. GC Pharma Recent Developments/Updates
Table 95. Shanghai Raas Corp Corporation Information
Table 96. Shanghai Raas Corp Description and Business Overview
Table 97. Shanghai Raas Corp Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Shanghai Raas Corp Human Factor VIII Concentrate Product
Table 99. Shanghai Raas Corp Recent Developments/Updates
Table 100. Hualan Biological Corporation Information
Table 101. Hualan Biological Description and Business Overview
Table 102. Hualan Biological Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Hualan Biological Human Factor VIII Concentrate Product
Table 104. Hualan Biological Recent Developments/Updates
Table 105. Shandong Taibang Biological Products Corporation Information
Table 106. Shandong Taibang Biological Products Description and Business Overview
Table 107. Shandong Taibang Biological Products Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Shandong Taibang Biological Products Human Factor VIII Concentrate Product
Table 109. Shandong Taibang Biological Products Recent Developments/Updates
Table 110. Shanghai Xinxing Medicine Corporation Information
Table 111. Shanghai Xinxing Medicine Description and Business Overview
Table 112. Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product
Table 114. Shanghai Xinxing Medicine Recent Developments/Updates
Table 115. SinoCell Tech Corporation Information
Table 116. SinoCell Tech Description and Business Overview
Table 117. SinoCell Tech Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. SinoCell Tech Human Factor VIII Concentrate Product
Table 119. SinoCell Tech Recent Developments/Updates
Table 120. CSL Corporation Information
Table 121. CSL Description and Business Overview
Table 122. CSL Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. CSL Human Factor VIII Concentrate Product
Table 124. CSL Recent Developments/Updates
Table 125. Grifols Corporation Information
Table 126. Grifols Description and Business Overview
Table 127. Grifols Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Grifols Human Factor VIII Concentrate Product
Table 129. Grifols Recent Developments/Updates
Table 130. Biogen Corporation Information
Table 131. Biogen Description and Business Overview
Table 132. Biogen Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Biogen Human Factor VIII Concentrate Product
Table 134. Biogen Recent Developments/Updates
Table 135. Octapharma Corporation Information
Table 136. Octapharma Description and Business Overview
Table 137. Octapharma Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Octapharma Human Factor VIII Concentrate Product
Table 139. Octapharma Recent Developments/Updates
Table 140. NovoNordisk Corporation Information
Table 141. NovoNordisk Description and Business Overview
Table 142. NovoNordisk Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. NovoNordisk Human Factor VIII Concentrate Product
Table 144. NovoNordisk Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Human Factor VIII Concentrate Distributors List
Table 148. Human Factor VIII Concentrate Customers List
Table 149. Human Factor VIII Concentrate Market Trends
Table 150. Human Factor VIII Concentrate Market Drivers
Table 151. Human Factor VIII Concentrate Market Challenges
Table 152. Human Factor VIII Concentrate Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Human Factor VIII Concentrate
Figure 2. Global Human Factor VIII Concentrate Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Human Factor VIII Concentrate Market Share by Type in 2022 & 2029
Figure 4. Blood Extraction Product Picture
Figure 5. Recombine Product Picture
Figure 6. Global Human Factor VIII Concentrate Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Human Factor VIII Concentrate Market Share by Application in 2022 & 2029
Figure 8. Congenital Coagulation Factor VIII Deficiency
Figure 9. Acquired Factor VIII Deficiency
Figure 10. Von Willebrand's Disease
Figure 11. Global Human Factor VIII Concentrate Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Human Factor VIII Concentrate Market Size (2018-2029) & (US$ Million)
Figure 13. Global Human Factor VIII Concentrate Sales (2018-2029) & (K Units)
Figure 14. Global Human Factor VIII Concentrate Average Price (US$/Unit) & (2018-2029)
Figure 15. Human Factor VIII Concentrate Report Years Considered
Figure 16. Human Factor VIII Concentrate Sales Share by Manufacturers in 2022
Figure 17. Global Human Factor VIII Concentrate Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Human Factor VIII Concentrate Players: Market Share by Revenue in 2022
Figure 19. Human Factor VIII Concentrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Human Factor VIII Concentrate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 22. North America Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 23. United States Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 26. Europe Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 27. Germany Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Human Factor VIII Concentrate Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Human Factor VIII Concentrate Revenue Market Share by Region (2018-2029)
Figure 34. China Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 42. Latin America Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Human Factor VIII Concentrate by Type (2018-2029)
Figure 52. Global Revenue Market Share of Human Factor VIII Concentrate by Type (2018-2029)
Figure 53. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Human Factor VIII Concentrate by Application (2018-2029)
Figure 55. Global Revenue Market Share of Human Factor VIII Concentrate by Application (2018-2029)
Figure 56. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2018-2029)
Figure 57. Human Factor VIII Concentrate Value Chain
Figure 58. Human Factor VIII Concentrate Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Figure 1. Product Picture of Human Factor VIII Concentrate
Figure 2. Global Human Factor VIII Concentrate Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Human Factor VIII Concentrate Market Share by Type in 2022 & 2029
Figure 4. Blood Extraction Product Picture
Figure 5. Recombine Product Picture
Figure 6. Global Human Factor VIII Concentrate Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Human Factor VIII Concentrate Market Share by Application in 2022 & 2029
Figure 8. Congenital Coagulation Factor VIII Deficiency
Figure 9. Acquired Factor VIII Deficiency
Figure 10. Von Willebrand's Disease
Figure 11. Global Human Factor VIII Concentrate Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Human Factor VIII Concentrate Market Size (2018-2029) & (US$ Million)
Figure 13. Global Human Factor VIII Concentrate Sales (2018-2029) & (K Units)
Figure 14. Global Human Factor VIII Concentrate Average Price (US$/Unit) & (2018-2029)
Figure 15. Human Factor VIII Concentrate Report Years Considered
Figure 16. Human Factor VIII Concentrate Sales Share by Manufacturers in 2022
Figure 17. Global Human Factor VIII Concentrate Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Human Factor VIII Concentrate Players: Market Share by Revenue in 2022
Figure 19. Human Factor VIII Concentrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Human Factor VIII Concentrate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 22. North America Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 23. United States Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 26. Europe Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 27. Germany Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Human Factor VIII Concentrate Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Human Factor VIII Concentrate Revenue Market Share by Region (2018-2029)
Figure 34. China Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 42. Latin America Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Human Factor VIII Concentrate Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Human Factor VIII Concentrate Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Human Factor VIII Concentrate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Human Factor VIII Concentrate by Type (2018-2029)
Figure 52. Global Revenue Market Share of Human Factor VIII Concentrate by Type (2018-2029)
Figure 53. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Human Factor VIII Concentrate by Application (2018-2029)
Figure 55. Global Revenue Market Share of Human Factor VIII Concentrate by Application (2018-2029)
Figure 56. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2018-2029)
Figure 57. Human Factor VIII Concentrate Value Chain
Figure 58. Human Factor VIII Concentrate Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
